Recombinant TNFSF4 (Oxelumab Biosimilar) antibody
-
- Target See all TNFSF4 (Oxelumab Biosimilar) products
- TNFSF4 (Oxelumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
-
Clonality
- Monoclonal
-
Conjugate
- This TNFSF4 (Oxelumab Biosimilar) antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), Blocking Reagent (BR)
- Specificity
- Binds to human OX40L.
- Characteristics
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Purification
- Purified antibody.
- Purity
- > 98 % as determined by SDS-PAGE
- Endotoxin Level
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogen
- Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
- Clone
- R4930
- Isotype
- IgG1 kappa
-
-
- Application Notes
- This antibody binds to the co-stimulatory OX40L, inhibiting its interaction with OX40.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- TNFSF4 (Oxelumab Biosimilar)
- Abstract
- TNFSF4 (Oxelumab Biosimilar) Products
- Synonyms
- CD134L antibody, CD252 antibody, GP34 antibody, OX-40L antibody, OX4OL antibody, TXGP1 antibody, TNF superfamily member 4 antibody, TNFSF4 antibody
- Target Type
- Biosimilar
- Background
- CD252, TNFSF4, tumor necrosis factor (TNF) superfamily member 4, OX40 ligand, OX-40L, TAX transcriptionally-activated glycoprotein 1, TXGP1, gp34
- UniProt
- P23510
-